Anhui Huaheng Biotechnology Co., Ltd. (688639.SS)
CNY 28.47
(-0.11%)
CNY 28.47
(-0.11%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.93 Billion CNY | 36.63% |
| 2022 | 1.41 Billion CNY | 48.69% |
| 2021 | 954.09 Million CNY | 95.81% |
| 2020 | 487.24 Million CNY | -0.83% |
| 2019 | 491.31 Million CNY | 16.74% |
| 2018 | 420.84 Million CNY | 10.01% |
| 2017 | 382.54 Million CNY | 22.85% |
| 2016 | 311.39 Million CNY | 22.85% |
| 2015 | 253.47 Million CNY | 12.72% |
| 2014 | 224.86 Million CNY | 29.68% |
| 2013 | 173.4 Million CNY | 100.05% |
| 2012 | 86.67 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 522.81 Million CNY | 1.43% |
| 2024 Q2 | 515.43 Million CNY | 3.48% |
| 2024 Q1 | 498.12 Million CNY | -13.23% |
| 2023 Q3 | 514.27 Million CNY | 14.38% |
| 2023 FY | 1.93 Billion CNY | 36.63% |
| 2023 Q4 | 574.1 Million CNY | 11.63% |
| 2023 Q2 | 449.63 Million CNY | 12.34% |
| 2023 Q1 | 400.25 Million CNY | -7.96% |
| 2022 FY | 1.41 Billion CNY | 48.69% |
| 2022 Q4 | 434.87 Million CNY | 22.55% |
| 2022 Q3 | 354.86 Million CNY | -1.01% |
| 2022 Q2 | 358.5 Million CNY | 32.58% |
| 2022 Q1 | 270.4 Million CNY | -18.78% |
| 2021 Q1 | 165.07 Million CNY | 30.3% |
| 2021 FY | 954.09 Million CNY | 95.81% |
| 2021 Q4 | 332.94 Million CNY | 37.85% |
| 2021 Q3 | 241.51 Million CNY | 12.56% |
| 2021 Q2 | 214.56 Million CNY | 29.98% |
| 2020 Q2 | 128.67 Million CNY | -0.85% |
| 2020 Q4 | 126.68 Million CNY | 24.08% |
| 2020 Q3 | 102.09 Million CNY | -20.66% |
| 2020 Q1 | 129.78 Million CNY | 7.1% |
| 2020 FY | 487.24 Million CNY | -0.83% |
| 2019 FY | 491.31 Million CNY | 16.74% |
| 2019 Q3 | 110.78 Million CNY | 0.0% |
| 2019 Q4 | 121.18 Million CNY | 9.39% |
| 2018 FY | 420.84 Million CNY | 10.01% |
| 2017 Q2 | 94.29 Million CNY | 0.0% |
| 2017 FY | 382.54 Million CNY | 22.85% |
| 2017 Q1 | 94.29 Million CNY | 5.8% |
| 2016 Q1 | 66.57 Million CNY | 10.88% |
| 2016 Q4 | 89.12 Million CNY | 0.0% |
| 2016 FY | 311.39 Million CNY | 22.85% |
| 2016 Q3 | 89.12 Million CNY | 33.87% |
| 2016 Q2 | 66.57 Million CNY | -0.0% |
| 2015 Q4 | 60.03 Million CNY | 0.0% |
| 2015 Q3 | 60.03 Million CNY | -9.98% |
| 2015 Q2 | 66.69 Million CNY | 0.0% |
| 2015 FY | 253.47 Million CNY | 12.72% |
| 2015 Q1 | 66.69 Million CNY | 20.34% |
| 2014 FY | 224.86 Million CNY | 29.68% |
| 2014 Q4 | 55.42 Million CNY | 0.0% |
| 2014 Q3 | 55.42 Million CNY | -2.79% |
| 2014 Q2 | 57.01 Million CNY | 0.0% |
| 2014 Q1 | 57.01 Million CNY | 23.15% |
| 2013 Q3 | 46.29 Million CNY | 14.58% |
| 2013 Q2 | 40.4 Million CNY | -0.0% |
| 2013 Q1 | 40.4 Million CNY | 0.0% |
| 2013 FY | 173.4 Million CNY | 100.05% |
| 2013 Q4 | 46.29 Million CNY | 0.0% |
| 2012 FY | 86.67 Million CNY | 0.0% |